---
layout: default
title: Data Sources
nav_order: 93
permalink: /sources/
description: "Data sources behind ZaTxGNN: SAHPRA registration data, TxGNN, ClinicalTrials.gov, PubMed and DrugBank."
---

# Data Sources

<div class="key-takeaway">
Every conclusion traces back to a public data source — nothing is a black box.
</div>

---

## Source overview

<table class="comparison-table">
<thead>
<tr><th>Type</th><th>Source</th><th>Used for</th></tr>
</thead>
<tbody>
<tr><td>Registration data</td><td><a href="https://www.sahpra.org.za/">SAHPRA</a></td><td>Approved drug list and ingredients for South Africa</td></tr>
<tr><td>Prediction model</td><td><a href="https://zitniklab.hms.harvard.edu/projects/TxGNN/">TxGNN</a></td><td>Drug&ndash;disease association prediction</td></tr>
<tr><td>Clinical trials</td><td><a href="https://clinicaltrials.gov/">ClinicalTrials.gov</a></td><td>Evidence grading (NCT)</td></tr>
<tr><td>Literature</td><td><a href="https://pubmed.ncbi.nlm.nih.gov/">PubMed</a></td><td>Evidence grading (PMID)</td></tr>
<tr><td>Drug information</td><td><a href="https://go.drugbank.com/">DrugBank</a></td><td>Ingredient mapping and target data</td></tr>
<tr><td>Interactions</td><td><a href="https://ddinter2.scbdd.com/">DDInter</a></td><td>Drug&ndash;drug interaction data</td></tr>
</tbody>
</table>

---

## Licensing

Each source has its own licence — please check before citing:

- **TxGNN**: academic use; cite Huang et al. (2023)
- **ClinicalTrials.gov / PubMed**: US NIH public data
- **DrugBank**: non-commercial use subject to its licence terms
- **SAHPRA**: subject to the open data terms of the South Africa regulator

---

## Update frequency

| Data | Frequency |
|------|-----------|
| Registration data | As published by the regulator |
| Trial / literature evidence | Re-collected periodically |
| Interaction data | Reviewed quarterly |

---

## Academic citation

> Huang, K., et al. (2023). A foundation model for clinician-centered drug repurposing. *Nature Medicine*.
> [DOI: 10.1038/s41591-023-02233-x](https://doi.org/10.1038/s41591-023-02233-x)

---

## About the Developer

This platform is developed and operated by **藥提醒科技有限公司** (yao.care, company registration
number 83620786, 12F, No. 220, Sec. 2, Taiwan Blvd., West Dist., Taichung City, Taiwan).

ZaTxGNN is the South Africa site of the company's "TxGNN Drug Repurposing" product line.
The same system is deployed across 30 countries and regions, each named `{CC}TxGNN`
(JpTxGNN, UsTxGNN, DETxGNN, and so on) at `{cc}txgnn.yao.care`.
Product overview: <https://www.yao.care/medical/txgnn/>.

The TxGNN model itself was developed by the Zitnik Lab at Harvard Medical School and published
in *Nature Medicine*. This platform is the production system 藥提醒科技有限公司 built on top of that
model, covering national drug-registration data integration, dual knowledge-graph and
deep-learning prediction, PubMed / ClinicalTrials evidence grading, and SMART on FHIR
electronic health record integration.

---

<div class="disclaimer">
<strong>Disclaimer</strong><br>
This report is for academic research reference only and <strong>does not constitute medical advice</strong>. Always follow your physician's instructions; never adjust medication on your own. Any drug repurposing decision requires full clinical validation and regulatory review.
<br><br>
<small>Reviewed by: 藥提醒科技有限公司 (yao.care)</small>
</div>
